INCY vs XMTR · P/E 14, rev $5.14B vs rev $434.4M
Incyte Corporation (INCY) versus Xometry Inc (XMTR) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Xometry Inc (XMTR) is a industrial distribution company listed on NASDAQ.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported XMTR revenue for 2026-06-30 was $434.4M. Net income was -$10.6M. XMTR currently screens at market cap $4.81B.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. XMTR currently screens at market cap $4.81B.
Not investment advice. Open the INCY and XMTR stock pages for the full models.
Not investment advice.